Verve Therapeutics
About Us
Why Heart Disease
Approach
Culture & Careers
News
Contact Us
Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing
Post navigation
Next Post
Next
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
Home
About Us
Why Heart Disease
Approach
Culture & Careers
News
Contact Us